Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index; 1 of the 76 sources its claims cite were checked for support.
Abstract
Alzheimer's disease (AD) is characterized by amyloid plaques composed of the β-amyloid (Aβ) peptide surrounded by swollen presynaptic dystrophic neurites consisting of dysfunctional axons and terminals that accumulate the β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) required for Aβ generation. The cellular and molecular mechanisms that govern presynaptic dystrophic neurite formation are unclear, and elucidating these processes may lead to novel AD therapeutic strategies. Previous studies suggest Aβ may disrupt microtubules, which we hypothesize have a critical role in the development of presynaptic dystrophies. To investigate this further, here we have assessed the effects of Aβ, particularly neurotoxic Aβ42, on microtubules during the formation of presynaptic dystrophic neurites in vitro and in vivo. Live-cell imaging of primary neurons revealed that exposure to Aβ42 oligomers caused varicose and beaded neurites with extensive microtubule disruption, and inhibited anterograde and retrograde trafficking. In brain sections from AD patients and the 5XFAD transgenic mouse model of amyloid pathology, dystrophic neurite halos with BACE1 elevation around amyloid plaques exhibited aberrant tubulin accumulations or voids. At the ultrastructural level, peri-plaque dystrophies were strikingly devoid of microtubules and replete with multi-lamellar vesicles resembling autophagic intermediates. Proteins of the microtubule motors, kinesin and dynein, and other neuronal proteins were aberrantly localized in peri-plaque dystrophies. Inactive pro-cathepsin D also accumulated in peri-plaque dystrophies, indicating reduced lysosomal function. Most importantly, BACE1 accumulation in peri-plaque dystrophies caused increased BACE1 cleavage of APP and Aβ generation. Our study supports the hypothesis that Aβ induces microtubule disruption in presynaptic dystrophic neurites that surround plaques, thus impairing axonal transport and leading to accumulation of BACE1 and exacerbation of amyloid pathology in AD.
Overview
CoChat Summary
TL;DR
This study shows that Aβ42 oligomers disrupt microtubules and cause neuritic beading in primary neurons, and that BACE1-positive peri-plaque dystrophic neurites in AD and 5XFAD mice lack intact microtubules, mislocalize motor proteins, and accumulate BACE1-cleaved APP products including Aβ42. The authors propose a feed-forward mechanism in which local Aβ toxicity impairs axonal transport, causing BACE1/APP accumulation and increased Aβ generation around plaques.
Key findings
- In primary cortical neurons, 1 μM Aβ42 oligomers for 72 h caused βIII-tubulin accumulations and neuritic beading; live imaging with 10 μM Aβ42 showed microtubule disruption and beading as early as 3.5 h, with a small but significant decrease in Tubulin Tracker fluorescence ratio versus vehicle (p = 0.004) and no increase in propidium iodide-labeled dead cells at 3.5 h.
- In post-mortem AD superior temporal gyrus (3 AD, 3 controls) and 5XFAD mouse brain, BACE1-positive peri-plaque dystrophies showed reduced βIII-tubulin, acetylated α-tubulin, and polyglutamylated tubulin immunostaining, with significantly elevated BACE1/tubulin intensity ratios versus normal neuropil (p < 0.001).
- By EM, peri-plaque dystrophic axons in 5XFAD mice were filled with multilamellar vesicles and were strikingly devoid of intact microtubules; dynein intermediate chain and p150glued were reduced in dystrophies, while dynamitin and kinesin heavy chain accumulated.
- 5XFAD cortex had nearly twofold higher immature pro-cathepsin D than non-transgenic cortex, while mature cathepsin D heavy chain was not significantly changed; peri-plaque dystrophies also showed increased sAPPβ, 3D6/Aβ, and Aβ42 neoepitope immunoreactivity co-localizing with BACE1, indicating increased BACE1 cleavage of APP and Aβ generation.
Methods
- Primary mouse cortical neurons (E15.5–16.5 C57BL/6) were treated with Aβ42 oligomers or vehicle and analyzed by immunofluorescence, live-cell Tubulin Tracker imaging, propidium iodide labeling, and kymograph analysis of BACE1-YFP and NPY-mCherry trafficking.
- Human post-mortem superior temporal gyrus from three AD patients and three cognitively normal controls was immunostained for BACE1, tubulin isoforms, and methoxy XO4; at least 10 plaques per case were imaged.
- 5XFAD and 5XFAD;BACE1−/− mice were analyzed by immunofluorescence, electron microscopy, and immunoblotting; for proteins not previously published, 5–8 male and female 5XFAD mice at 5–6 or 9 months were used, with 20–40 plaques imaged per antibody stain.
Limitations
- The paper states that post-mortem AD brain represents end-stage disease and provides limited information about pathogenesis; it also states that it cannot formally exclude APP processing elsewhere followed by product trafficking to dystrophies, and cannot exclude that some BACE1-positive dystrophies are post-synaptic/dendritic.
- The paper notes that the in vitro Aβ42 oligomer concentrations (1–10 μM) were used to model high local peri-plaque concentrations, that absolute soluble Aβ concentrations immediately around plaques were not quantified, and that the relationship between in vitro and in vivo results requires further investigation.
- Evident from the text: human tissue analysis used a small sample (three AD and three control cases), and much of the mechanistic evidence is correlative across a transgenic mouse model and cultured neurons rather than direct causal testing in human brain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Microtubule disruption in primary neurons is an early response to oligomeric Aβ42. Primary cortical neurons were cultured as in Fig. 1, and after 12 days in vitro, were labeled for 30 min with 250 nM Tubulin Tracker, rinsed, and then exposed to 10 μM Aβ42 oligomers or vehicle. Live imaging on an Andor spinning disk confocal microscope began 30 min after addition of Aβ42. a Fluorescence and differential interference contrast (DIC) images were acquired every 5 min for 3 h. Neurite beading, microtubule accumulation in varicosities (arrowheads), and microtubule fragmentation (arrows) in neurites were present 3.5 h after Aβ42 addition, in the absence of significant cell death or BACE1 elevation [49]. In contrast, the morphology of vehicle-treated neurons was unaffected, with the exception of a moderate decrease of fluorescence intensity. DIC imaging revealed that neurites of Aβ42-treated neurons were intact and continuous, even though they exhibited beading and microtubule fragmentation, indicating that the observed microtubule disruption was not the result of physical degeneration of neurites. Insets show higher magnification images of the boxed region of the Aβ42-treated culture to accentuate varicosity formation and microtubule fragmentation. b The ratios of Tubulin Tracker fluorescence intensity (Int.) at 3.5 h (hours) to that at 0.5 h after Aβ42 treatment were calculated for 46 image fields from two separate experiments and averaged for Aβ42-treated and vehicle-treated neurons. Overall Tubulin Tracker fluorescence intensity decreased in neurons over time due to photo-bleaching, as indicated by fluorescence intensity ratios below 1. Nevertheless, the Tubulin Tracker fluorescence intensity ratio for Aβ42-treated neurons showed a small but highly significant decrease compared to vehicle treatment (p = 0.004), suggesting microtubule depolymerization and reduced stability of microtubule networks after only 3.5 h of Aβ42 exposure. Error bars SEM; **, p < 0.01. c To investigate longer Aβ42 treatment times and minimize photo-bleaching, primary neuron cultures were prepared as above and images collected once every 60 min for 6 h. Neurite beading, aberrant microtubule localization, and microtubule fragmentation were even more prevalent and pronounced in neurons after 6.5 h compared to 3.5 h of Aβ42 treatment, while vehicle-treated neurites continued to appear normal. Scale bars 20 μm for all images in a, c](https://figures.cochat.ai/paper-figures/3acf268020524b74be0244d32e519f8d/presynaptic-dystrophic-neurites-surrounding-amyloid-plaques-are-sites-of-figure-2.jpg)
![Fig. 3 Tubulin isoforms are aberrantly localized in BACE1-positive peri-plaque dystrophic neurites in vivo. a Post-mortem brain sections of superior frontal gyrus from three AD patients and three cognitively normal controls were stained with antibodies against BACE1 (red) and βIII-tubulin (green), and methoxy XO4 (blue) to label amyloid deposits. Representative plaques from two cases (AD 14–190 and AD 11–193, Columns 1–2) are shown; additional examples in Fig. S2. Cognitively normal controls were negative for plaques, as expected (not shown). As previously reported [86], BACE1 immunostaining was observed in a halo of dystrophic neurites surrounding individual plaques. In contrast, βIII-tubulin immunostaining was almost entirely absent in peri-plaque BACE1-positive dystrophies. Non-dystrophic neuropil in areas adjacent to plaques exhibited normal intensities and patterns of βIII-tubulin immunostaining. Some red fluorescence (white arrows) represents non-specific background from blood vessels. Brain sections from the aggressive amyloid 5XFAD mouse model were stained with antibodies against BACE1 (red) and βIII-tubulin, acetylated α-tubulin or polyglutamylated tubulin (green). Representative 5XFAD amyloid deposits are shown (Columns 3–5), with plaque cores marked by asterisks; additional examples in Fig. S2. Similar to human AD, BACE1 accumulated in peri-plaque dystrophic neurites in 5XFAD brain sections. Additionally, the different tubulin isoforms were generally reduced in dystrophic halos around plaques, although tubulins often occurred in amorphous accumulations that showed little co-localization with BACE1 immunostaining. Scale bars in all frames 10 μm. b Immunofluorescence intensities of BACE1 and tubulin isoforms (as indicated at top of each column) in peri-plaque dystrophic neurites were measured and BACE1/tubulin intensity ratios calculated and compared to those in normal-appearing regions of neuropil within the same frame (Supplementary Methods). For human tissue, 16 dystrophies and corresponding non-dystrophic regions were measured per case. For murine tissue, BACE1/tubulin isoform ratios were determined for 11–20 BACE1-positive dystrophic regions and a corresponding number of nearby neuropil areas. BACE1/tubulin ratios for AD 14–190 and AD 11–193 (Panels 1 and 2, respectively) and 5XFAD mice (Panels 3–5) are shown. While there was substantial variation for dystrophic neurites, BACE1/tubulin intensity ratios for dystrophies were significantly elevated compared to those for normal neuropil for both AD cases and 5XFAD mice. Error bars SEM; ***p < 0.001. c The quantitative relationships between BACE1 and tubulin isoform immunofluorescence intensities by another method, intensity profiles as a function of distance across the plaque were generated (Supplementary Methods). Representative plaques are shown (upper row) for AD 14–190 and AD 11–193 (Panels 1 and 2, respectively) and 5XFAD mice (Panels 3–5). White line indicates path through plaque from which the intensity profiles were generated (bottom row). Note the inverse relationships between BACE1 and tubulin intensities as a function of distance across the plaque in each case. Taken together, these results suggest that tubulin, and hence microtubules, is reduced and/or mis-localized in peri-plaque dystrophic neurites. AU arbitrary units. Scale bars in all frames 10 μm](https://figures.cochat.ai/paper-figures/ae61329cce564444a96fa03fe061bf5e/presynaptic-dystrophic-neurites-surrounding-amyloid-plaques-are-sites-of-figure-3.jpg)
![Fig. 4 Microtubules are strikingly absent in peri-plaque dystrophic axons. 5XFAD brain tissue was prepared for electron microscopy (EM) and assessed ultrastructurally for the presence of microtubules in peri-plaque dystrophic axons. a As previously reported [25], electron microscopy of 5XFAD brain revealed amyloid plaques (p) surrounded by dystrophic neurites (representative examples outlined in blue) filled with electron-dense multi-lamellar vesicles, possibly autophagic intermediates. b EM of a transverse section through a pair of dystrophic myelinated axons filled with multi-lamellar vesicles. Note that the lower portion of the axon on the left has lost its myelin sheath. c–f EM of serial ultrathin sections occasionally revealed series of longitudinal sections through dystrophic axons near amyloid plaques. Shown is such a series of a peri-plaque dystrophic myelinated axon with a portion of normal axon appearing on the left side of the dystrophy. Intact, continuous microtubules (yellow shading) are present in the morphologically normal part of the axon, but then microtubules become disorganized and mostly disappear within the dystrophic region. Note the dark outline of the surrounding myelin sheath, definitively confirming axonal identity. These ultrastructural images provide direct evidence that microtubules are disrupted and largely absent in peri-plaque dystrophic regions of axons. Images are spaced ~200 nm apart. f Higher magnification of rectangle in e. Scale bars 1 μm](https://figures.cochat.ai/paper-figures/6c71f487ac0c445e929142ba649fa4e4/presynaptic-dystrophic-neurites-surrounding-amyloid-plaques-are-sites-of-figure-4.jpg)



![Fig. 8 Neoepitope antibodies recognize BACE1-cleaved APP and Aβ but not full-length APP in vivo. Sagittal brain sections of 5XFAD;BACE1+/+ and 5XFAD;BACE1−/− mice were immunostained with neoepitope antibodies to a the free C-terminus of BACE1-cleaved APP ectodomain ending in the Swedish mutation, sAPPβ (antibody ANJJ [45, 46], green), b the free N-terminus of BACE1-cleaved Aβ (antibody 3D6 [23], red), or c the free C-terminus of γ-secretase-cleaved Aβ42 (green). Sections were also co-immunostained with an antibody recognizing full-length APP (antibody Karen [64], red), then imaged by confocal microscopy. All three neoepitope immunoreactivities were present in soma (arrows), and processes in the case of sAPPβ (arrowheads), of pyramidal neurons in the cortex of 5XFAD;BACE1+/+ mice, while none were detected in 5XFAD;BACE1−/− cortex, despite overexpression of transgenic APP in pyramidal neurons of both genotypes. These data confirm that ANJJ, 3D6, and Aβ42 antibodies are selective for their respective neoepitopes and do not cross-react to full-length APP. DAPI staining (blue) identified nuclei and autofluorescence of amyloid deposit cores (marked by asterisks). Note that amyloid deposits are completely lacking in 5XFAD;BACE1−/− cortex, as previously reported [41]. Scale bars 10 μm (b), 20 μm (a)](https://figures.cochat.ai/paper-figures/bd45e1b9c4ab4415ab22ba58bd792238/presynaptic-dystrophic-neurites-surrounding-amyloid-plaques-are-sites-of-figure-8.jpg)

Verification
Claims the paper makes
1 Valid · 0 Not valid · 43 Not checked · 138 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“BACE1 immunoreactivity was concentrated in a halo surrounding the core of the amyloid deposit, as previously reported [25,85,86].”
§ Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease > Tubulin is aberrantly localized and microtubules are disrupted in peri-plaque presynaptic dystrophic neurites in vivo
What the sources say
- Supportedcites [25] 25. Kandalepas PC, Sadleir KR, Eimer WA, Zhao J, Nicholson DA, Vassar R (2013) The Alzheimer's beta-secretase BACE1 local- izes to normal presynaptic terminals and to dystrophic presyn- aptic terminals surrounding amyloid plaques. Acta Neuropathol 126:329-352. doi:10.1007/s00401-013-1152-3 source
The Results section 'BACE1 is localized within endocytic vesicles of dystrophic presynaptic terminals in the APP transgenic brain at the ultrastructural level' (p. ~4) states that in 5XFAD hippocampal/cortical sections 'BACE1 immunoreactivity was aberrantly localized to an annulus surrounding each amyloid plaque (Fig. 4d, g)', i.e. a halo around the plaque, and recalls that BACE1 'accumulates in synaptophysin-positive structures surrounding the cores of amyloid plaques'. The Discussion (same subsection) extends the same peri-plaque pattern to human AD brain, confirming the model recapitulates it. The claim's paraphrase of 'annulus' as 'halo' and its attribution to 5XFAD mice match our copy. (LLM, conf=0.92)
- Not checked yetcites [85] 85. Zhang XM, Cai Y, Xiong K, Cai H, Luo XG, Feng JC, Clough RW, Struble RG, Patrylo PR, Yan XX (2009) Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur J Neurosci 30:2271-2283. doi:10.1111/j.1460-9568.2009.07017.x source
- Not checked yetcites [86] 86. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R (2007) Beta- site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 27:3639-3649 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“differential interference contrast microscopy indicated that most of the neurites with beads or aberrant microtubule organization were still continuous and intact, although morphologically abnormal (Figs.2a, S1).”
§ Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease > Aβ42 causes neuritic beading and microtubule disruption in primary neurons in vitro
hedgedn = 6- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Inactive pro-cathepsin D also accumulated in peri-plaque dystrophies, indicating reduced lysosomal function.”
§ Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, the different tubulin isoforms were generally reduced in dystrophic halos around plaques, although tubulins often occurred in amorphous accumulations that showed little co-localization with BACE1 immunostaining.”
§ Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease > Tubulin is aberrantly localized and microtubules are disrupted in peri-plaque presynaptic dystrophic neurites in vivo
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found swollen dystrophic neurites in abundance in close proximity or virtually contacting amyloid deposits (Fig. 4a).”
§ Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease > Tubulin is aberrantly localized and microtubules are disrupted in peri-plaque presynaptic dystrophic neurites in vivo
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
99 more claims
Create a free account to see all 182 claims and to verify the 75 references still open.
- It may state two separate claims as one. 61
- Probably not a substantial claim. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-pressure freezing EM analyses showed that myelin-damage-associated swellings were enriched in vesicular structures that were probably endosomal or lysosomal in origin (Fig. 3a), which are thought to be primary production sites of Aβ32,33.”
From Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The endosomal-lysosomal network is dysfunctional in Alzheimer's disease (AD), evident from the accumulation of autophagic vacuoles in the axons of dystrophic neurites due to disruption of retrograde trafficking, acidification, and maturation of endo-lysosomes (Gowrishankar et al., 2015;Lie et al., 2022;Sadleir et al., 2016;Serrano-Pozo et al., 2016).”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Sadleir et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The DNs, termed amyloid-associated axonal spheroids, are globular in shape and have pathological structures that contain cytoskeletal elements, pathological proteins, and damaged organelles, in addition to enzymes involved in amyloid precursor protein (APP) processing [13, 64, 68, 82].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The formation and aggregation of Aβ fibrils is central to extracellular Aβ plaques, which are accompanied by dystrophic neurites (DNs) comprising swollen axons and terminals [64].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Notably, a relatively large accumulation of BACE1 was described in neuritic dystrophies in the vicinity of Aβ plaques both in AD amyloidogenic mouse models and in AD brains, most likely by a posttranslational mechanism (2,5,6).”
From The β-Secretase BACE1 in Alzheimer’s Disease (2021) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease > Human tissue immunofluorescence
“40-μm floating sections of superior temporal gyrus were stained and imaged as described for murine tissue”
§ Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease > Tubulin is aberrantly localized and microtubules are disrupted in peri-plaque presynaptic dystrophic neurites in vivo
“Post-mortem brain sections of superior frontal gyrus from three AD patients and three cognitively normal controls were stained with antibodies against BACE1”
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Aβ42 oligomer concentrations in the range of 1–10 μM induce cell death in primary neuron culture (reviewed in [16]).”
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 17×
“In this diagram, adapted from [14], we show that the ANJJ antibody [9,10], which recognizes the free C-terminal neoepitope of sAPPβ (green vertical line) created by BACE1 cleavage of APP carrying the Swedish mutation, will detect Aη-β and sAPPβ (green rectangles) but not sAPPη or Aη-α.”
InfluentialSelf-citationOakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 4×
“To gain insight into the development of Aβ-induced dystrophic neurites, we turned to our 5XFAD mouse model of amyloid pathology [40].”
InfluentialSelf-citationThe molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · cited 1×
“1 3 [24]) AD by increasing or decreasing BACE1 cleavage of APP and Aβ production, respectively.”
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Cited by
Items 201–300 of 338
HDAC6 regulates BACE1 stability and NLRP3 inflammasome activation in Alzheimer's disease
Lee, J., Cho, Y., Choi, B. Y., Kim, H. K., Lee, Y., Kim, E., Han, J., Sul, J. H., Kim, J. S., Baek, S. H., et al. (2026) · Brain · doi:10.1093/brain/awag089 · Cited by 5
Protein–Protein Interactions in Neurodegenerative Diseases
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_3 · Cited by 5
Romero‐Molina, C., Neuner, S. M., Ryszawiec, M., Pébay, A., Dominantly Inherited Alzheimer Network, Marcora, E. M., & Goate, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052565 · Cited by 5
Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?
Li, J., Huang, L., Liu, F., Tang, B., & Yan, X. (2017) · BMC Neurology · doi:10.1186/s12883-017-0942-y · Cited by 5
Panigrahy, S., Sikder, A., Amulya, E., Shah, S., Khairnar, P., Saraf, S., & Srivastava, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105325 · Cited by 5
Yuan, Q., Zhang, H., Zhang, X., Huang, P., Liu, R., Song, Y., Wu, W., & Lin, Z. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.037 · Cited by 5
Meco, A. D., Kemal, S., Popović, J., Chandra, S., Sadleir, K. R., & Vassar, R. J. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220509143823 · Cited by 5
Self-citationHulsman, M., Ganz, A. B., Zhang, M., Koopmans, F., Li, K. W., Miedema, S. S. M., Rohde, S. K., Luimes, M. C., Morrema, T. H. J., Rozemüller, A. J. M., et al. (2026) · medRxiv · doi:10.64898/2026.01.08.26343581 · Cited by 5
Zhang, Q., Lo, H., Song, Y., Feng, L., You, H., Chen, X., Wang, Y., & Pan, X. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03598-8 · Cited by 4
Kashif, O., & Said, M. (2025) · Discover Medicine · doi:10.1007/s44337-025-00455-x · Cited by 4
Aβ plaques induce local pre-synaptic toxicity in human iPSC-derived neuron xenografts
van Vierbergen, J. F. M., Calatayud, C., Balusu, S., Carrano, N., Peredo, N., Vints, K., Gallego, S. F., Horré, K., Strooper, B. D., & Verstreken, P. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102754 · Cited by 4
Shoff, T. A., Derbez-Morin, M., Cai, P., & Julian, R. R. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag034 · Cited by 5
Alzheimer’s Disease: From Pathogenesis to Emerging Therapeutic Targets
Takahashi, T., & Muguruma, K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062357 · Cited by 4
Maekawa, K., Sobue, A., Komine, O., Saito, Y., Murayama, S., Saido, T. C., Saito, T., & Yamanaka, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-98825-z · Cited by 4
Zhang, H., Pan, M., Ming-Tian, P., Yu-Xuan, L., Xiao-Jiang, L., Xiang-Yu, G., Da-Jian, H., 南方科技大学生命科学学院神经生物学系脑科学研究中心, 广. 深. 5., 临港实验室, 上. 2., & 暨南大学粤港澳中枢神经系统再生研究院, 中. (2025) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2025.077 · Cited by 4
Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice
Sadleir, K. R., Popovoic, J., Zhu, W., Reidel, C. T., Do, H., Silverman, R. B., & Vassar, R. J. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210713125333 · Cited by 4
Self-citationSwollen axons impair neuronal circuits in Alzheimer’s disease
Cobos, I., & Palop, J. J. (2022) · Nature · doi:10.1038/d41586-022-03800-7 · Cited by 4
Russo, M. L., Ayala, G. D., Neal, D., Rogalsky, A. E., Ahmad, S. J., Musial, T. F., Pearlman, M., Bean, L. A., Farooqi, A. K., Ahmed, A., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149083 · Cited by 4
Self-citationNeuropathology of a patient with Alzheimer disease treated with low doses of verubecestat
Querol‐Vilaseca, M., Sirisi, S., Molina‐Porcel, L., Molina-Esteve, B., Pegueroles, J., Ferrer‐Raventós, P., Núñez‐Llaves, R., Dols‐Icardo, O., Balasa, M., Iulita, M. F., et al. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12781 · Cited by 4
Soluble form of the APP fragment, sAPPβ, positively regulates tau secretion
Sato, H., Kasuga, K., Isoo, N., Hayashi, T., Ikeuchi, T., Hori, Y., & Tomita, T. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.03.002 · Cited by 4
Neuroinflammation in Alzheimer’s Disease
Kaity, S., & Kumar, A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_3 · Cited by 4
Silva‐Lucero, M., Rivera‐Osorio, J., Gomez‐Virgilio, L., López-Toledo, G., Luna‐Muñoz, J., Montiel-Sosa, J. F., Soto-Rojas, L. O., Pacheco‐Herrero, M., & Cárdenas‐Aguayo, M. D. C. (2022) · Diagnostics · doi:10.3390/diagnostics12051165 · Cited by 3
Zondagh, L. S., Malan, S. F., & Joubert, J. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106869 · Cited by 3
Bhansali, P. R., Sonkusare, S. M., Savale, S. S., Wijayasinghe, Y. S., Liao, Y., Sloan, D. C., Chaturbhuj, G. U., & Muntean, B. S. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2025.1642190 · Cited by 3
KIF2A downregulation links amyloid-β to Tau phosphorylation in Alzheimer’s disease
Ruiz-Reig, N., Virosztek, M., Chehade, G., Suelves, N., Zola, N. K. N., Salman, Y., Schakman, O., Kienlen‐Campard, P., Hanseeuw, B. J., & Tissir, F. (2025) · Brain · doi:10.1093/brain/awaf382 · Cited by 3
Amyloid Beta Oligomers as Early Triggers of Neuronal Cytoskeleton Dysfunction in Alzheimer’s Disease
Gasca-Martínez, Y., Ontiveros‐Torres, M. Á., López-Gallegos, I., & Jarero-Basulto, J. J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33010014 · Cited by 3
Lee, S., Ju, I. G., Eo, H., Kim, J. H., Choi, Y., & Oh, M. S. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00966-2 · Cited by 3
Alzheimer’s Disease: An Attempt of Total Recall
Bolshakov, A. P., Gerasimov, K., & Dobryakova, Y. V. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240620 · Cited by 3
Jia, C., Sun, Y., Chen, J., & Liu, X. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp00895f · Cited by 3
Gao, F., Lin, W., Zhao, T., Zhang, J., Pei, D., Di, D., Fan, Z., Yang, L., & Hai, J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02994 · Cited by 3
Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro
Ohki, E. C., Langan, T. J., Rodgers, K. R., & Chou, R. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00301 · Cited by 3
Su, Y., Wang, Q., Gao, F., Xu, J., Fu, J., Ying, Y., Xia, Y., Wang, X., Dong, Q., Shen, Y., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036204 · Cited by 4
Hernández-Contreras, K. A., Rojas-Durán, F., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Godínez‐Victoria, M., Manzo, J., Pérez-Estudillo, C. A., Ramos-Morales, F. R., Toledo‐Cárdenas, M. R., & Aranda-Abreu, G. E. (2025) · BioMed · doi:10.3390/biomed5010003 · Cited by 3
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez, E., Laurent, C. D. S., Cortez, L. M., Patel, Z. H., Sidhu, G., Sarkar, S., Aghanya, V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.04.547548 · Cited by 3
Jordá-Siquier, T., Petrel, M., Kouskoff, V., Cordelières, F. P., Frykman, S., Müller, U. C., Mulle, C., & Barthet, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.16.342196 · Cited by 3
Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease
Odfalk, K. F., Wickline, J. L., Smith, S., Dobrowolski, R., & Hopp, S. C. (2024) · Hippocampus · doi:10.1002/hipo.23586 · Cited by 2
“…disease (AD), evident from the accumulation of autophagic vacuoles in the axons of dystrophic neurites due to disruption of retrograde trafficking, acidification, and maturation of endo-lysosomes (Gowrishankar et al., 2015; Lie et al., 2022; Sadleir et al., 2016; Serrano-Pozo et al., 2016).”
BackgroundDu, J., Xu, G., Zhang, W., Cong, J., Si, X., & Wei, B. (2024) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2024.2419911 · Cited by 2
Sharma, N., Kim, D., Sharma, H., Kim, M. I., Lee, H., Kim, M., Ryoo, N., Kang, M. J., Pyun, J., Park, Y. H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70475 · Cited by 2
Characterization of novel mitochondrial modulators for the development of neuroprotective strategies
Lejri, I. (2016) · theses.fr (ABES) · doi:10.70675/92acb76bz3c28z48ebzb148zd851e13ec021 · Cited by 2
Morphologic features of synaptic structures associated with human cortical amyloid plaques
Гусельникова, В. В., Razenkova, V. A., Fedorova, E. A., & Korzhevsky, D. E. (2024) · Morphology · doi:10.17816/morph.634895 · Cited by 1
Franke, B. U., Kummer, K. K., Rose‐John, S., Lichtenthaler, S. F., & Kress, M. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156925 · Cited by 1
Wang, Y., Sun, Z., Zhou, P., Tu, T., Zhang, X.-J., Tu, E., Chen, H., Cheng, H.-Y., Pan, A., Zhang, Q., et al. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.03.032 · Cited by 1
Moliterni, C., Caissutti, D., Mandolini, E., Fasciolo, E., Çağlar, T. R., Capozzi, A., Misasi, R., & Candelise, N. (2026) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2026.1882543 · Cited by 1
Bellver‐Sanchís, A., Ralchev, N., Romanska, P. R., Dyakova, N. K., Ivanova, K. I., Griñán‐Ferré, C., & Marchev, A. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177833 · Cited by 1
Impact du VEGF sur les altérations synaptiques dans la maladie d’Alzheimer
Martin, L. (2018) · theses.fr (ABES) · doi:10.70675/e24b560ez70e5z4840z9195zde9043132aa0 · Cited by 1
Zhang, Q., Wang, Y., Coulibaly, S., Sun, Z.-P., Cai, X.-L., Tu, T., Liu, Y., Pan, A., Cui, M., Manavis, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.11.622955 · Cited by 1
Novel digital neuropathology methods applied to neurodegenerative diseases
Querol‐Vilaseca, M. (2020) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
3D human cortical brain organoids derived from hPSC to model health and disease in the human brain
Colinet, M. (2026) · ORBi (University of Liège) · Cited by 1
Rôle du peptide amyloïde dans les maladies neurodégénératives
Combes, M. (2018) · theses.fr (ABES) · doi:10.70675/a219ef4dzbca0z4272z8bf2z74080a1976e5 · Cited by 1
Danhash, E., Fang, S., Marsh, J. A., Albanus, R. D., Verbeck, A. C., Huang, G., You, S., Franklin, E. E., Perrin, R. J., Self, W. K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.22.740167 · Cited by 1
Astrocytic APOE3-Christchurch expression ameliorates brain amyloid-β pathology in 5xFAD mice
Raulin, A.-C., Alnobani, A., Rodriguez-Martinez, P., Lee, E., Linares, C., Yslas, A. R., Li, M., Ren, Y., Doss, S. V., Roy, B., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04002-9
Tillinghast, J. (2019) · Digital Commons (Liberty University)
On the Nature of β-Amyloid at Synapses
Martinsson, I. (2019) · Lund University Publications (Lund University)
Davison, L. R. (2020) · Arrow@dit (Dublin Institute of Technology)
Development of novel nucleic acid technologies for tackling neurological diseases
Chakravarthy, M. (2019) · Murdoch University Research Portal
McKeever, P. M. (2018) · TSpace (University of Toronto)
Variaciones de la respuesta microglial según el contexto patológico en la Enfermedad de Alzheimer
Romero‐Molina, C. (2021) · Deposito de Investigacion Universidad de Sevilla (University of Seville)
21116 基礎浮き上がり構造物の地震応答に及ぼす入力地震動位相特性の影響(相互作用(4):モデル化と応答,構造II)
氏家, 大., 麻里, 哲., & 緑川, 光. (2011) · 学術講演梗概集. B-2, 構造II, 振動, 原子力プラント
Xu, T., Xu, T., Han, Z.-Y., Dou, Y.-H., Shi, B., Dou, Y., Yang, J., Wang, Y., Chen, J., & Huang, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4052315
Yan, R. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736877185.793568031
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez, E., Laurent, C. D. S., Cortez, L. M., Patel, Z. H., Sidhu, G., Sarkar, S., Aghanya, V., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3147035/v1
Upadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144129
Self-citationUpadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144138
Self-citationUpadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144147
Self-citationUpadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144132
Self-citationUpadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144135
Self-citationUpadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144144
Self-citationUpadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincón-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144141
Self-citationHoshino, A., Castle, B. T., Shetty, M., Khan, H., Meints, J. P., Pletniková, O., Lee, M. K., Troncoso, J. C., Odde, D. J., & Bazzaro, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.26.671351
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612543
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614915
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612558
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez‐Cardona, E., Cortez, L. M., Patel, Z. H., Takahashi, K., St. Laurent, C. D., Sidhu, G., Sarkar, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26725883
Reich, N. (2023) · Lancaster EPrints (Lancaster University) · doi:10.17635/lancaster/thesis/2182
Tsering, W., Hery, G. P., Phillips, J. L., Lolo, K., Bathe, T., Villareal, J. A. B., Ruan, I. Y., & Prokop, S. (2024) · Figshare · doi:10.6084/m9.figshare.26648013
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612582
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614924
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614909
Upadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincon-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144123
Self-citationTran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612549
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612537
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612579
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612585
Upadhyay, A., Chhangani, D., Rao, N. R., Kofler, J., Vassar, R. J., Rincon-Limas, D. E., & Savas, J. N. (2023) · Figshare · doi:10.6084/m9.figshare.24144120
Self-citationTran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612564
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614918
Lee, S., Ju, I. G., Eo, H., Kim, J. H., Choi, Y., & Oh, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26182169
Delizannis, A. T., Nonneman, A., Tsering, W., Bondt, A. D., den Wyngaert, I. V., Zhang, B., Meymand, E. S., Olufemi, M. F., Koivula, P. P., Maimaiti, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16599810
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614921
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612546
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612534
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612555
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612570
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614927
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612567
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., Cunha, C. D., Phan, J., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612573
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614906
Metadata
- Authors
- Sadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R.
- Affiliations
- Northwestern University (US)
- The University of Texas MD Anderson Cancer Center (US)
- Rush University (US)
- University of Chicago (US)
- Corresponding author
- Vassar, Robert
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2016-03-18
- Volume
- 132
- Issue
- 2
- Pages
- 235-256
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4947125
- OpenAlex
- W2297442499
- Cited by
- 294
- References
- 91
- Citations by year
- 2026: 25 · 2025: 30 · 2024: 31 · 2023: 54 · 2022: 34 · 2021: 26 · 2020: 30 · 2019: 22 · 2018: 20 · 2017: 16 · 2016: 4
- FWCI
- 16.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Center for Strategic Scientific Initiatives, National Cancer Institute (P30 CA060553)
- National Center for Research Resources (1S10 RR031680-01)
- National Institutes of Health (1S10OD010398-01, T32-070715)
- National Institute on Aging (R01 AG030142, R01 AG019070, R01 AG13854)
- Cure Alzheimer's Fund (N/A)
- The Baila Foundation (N/A)
- BrightFocus Foundation
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, amyloid plaques, microtubule disruption, BACE1, amyloid-beta, Aβ42 oligomers, axonal transport, autophagy, kinesin, dynein, lysosomal dysfunction, cathepsin D, APP cleavage, 5xFAD mice
- MeSH terms
- Alzheimer Disease, Animals, Axons, Disease Models, Animal, Mice, Inbred C57BL, Mice, Transgenic, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Neurites, Amyloid beta-Protein Precursor, Presynaptic Terminals, Amyloid Precursor Protein Secretases, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.